ArticleRheumatology and therapy2022

Baseline Anti-Citrullinated Protein Antibody Status and Response to Abatacept or Non-TNFi Biologic/Targeted-Synthetic DMARDs: US Observational Study of Patients with RA.

Leslie R Harrold et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.